Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Activation of the Wnt signaling pathway: a molecular mechanism for lithium action.

Hedgepeth CM, Conrad LJ, Zhang J, Huang HC, Lee VM, Klein PS.

Dev Biol. 1997 May 1;185(1):82-91.

2.

The Yin-Yang of TCF/beta-catenin signaling.

Barker N, Morin PJ, Clevers H.

Adv Cancer Res. 2000;77:1-24. Review.

PMID:
10549354
3.

New steps in the Wnt/beta-catenin signal transduction pathway.

Sakanaka C, Sun TQ, Williams LT.

Recent Prog Horm Res. 2000;55:225-36. Review.

PMID:
11036939
4.

Modulation of Wnt signaling by Axin and Axil.

Kikuchi A.

Cytokine Growth Factor Rev. 1999 Sep-Dec;10(3-4):255-65. Review.

PMID:
10647780
5.
6.

Lithium-related genetics of bipolar disorder.

Detera-Wadleigh SD.

Ann Med. 2001 May;33(4):272-85. Review.

PMID:
11405549
7.

The Wnt signaling pathway in bipolar disorder.

Gould TD, Manji HK.

Neuroscientist. 2002 Oct;8(5):497-511. Review.

PMID:
12374432
8.

Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.

Gould TD, Manji HK.

Neuropsychopharmacology. 2005 Jul;30(7):1223-37. Review.

9.

Signal transduction in development: holding the key.

Harwood AJ.

Dev Cell. 2002 Apr;2(4):384-5. Review.

10.

Molecular targets of lithium action.

Phiel CJ, Klein PS.

Annu Rev Pharmacol Toxicol. 2001;41:789-813. Review.

PMID:
11264477
12.

Dictyostelium development: a prototypic Wnt pathway?

Harwood AJ.

Methods Mol Biol. 2008;469:21-32. doi: 10.1007/978-1-60327-469-2_2. Review.

PMID:
19109699
13.

Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes.

Jope RS.

Trends Pharmacol Sci. 2003 Sep;24(9):441-3. Review.

PMID:
12967765
14.

Targeting signal transduction pathways in the treatment of mood disorders: recent insights into the relevance of the Wnt pathway.

Gould TD, Dow ER, O'Donnell KC, Chen G, Manji HK.

CNS Neurol Disord Drug Targets. 2007 Jun;6(3):193-204. Review.

PMID:
17511616
15.

[The Relationship Between GSK-3 and Mental Disorders].

Yang J, Li JF, Zhao L.

Sheng Li Ke Xue Jin Zhan. 2015 Aug;46(4):250-4. Review. Chinese.

PMID:
26669074
16.

[Recent advances in neuroprotective mechanisms of lithium].

Jiao GH, Liu ZW, Zhang T.

Sheng Li Ke Xue Jin Zhan. 2007 Apr;38(2):165-7. Review. Chinese. No abstract available.

PMID:
17633237
17.

A bimodal model of the mechanism of action of lithium.

Jope RS.

Mol Psychiatry. 1999 Jan;4(1):21-5. Review.

PMID:
10089004
18.

The legacy of lithium effects on development.

Kao KR, Elinson RP.

Biol Cell. 1998 Nov;90(8):585-9. Review.

PMID:
10069003
19.

Prolyl oligopeptidase, inositol phosphate signalling and lithium sensitivity.

Harwood AJ.

CNS Neurol Disord Drug Targets. 2011 May;10(3):333-9. Review.

20.

Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol Hexakisphosphate.

Bizzarri M, Dinicola S, Bevilacqua A, Cucina A.

Int J Endocrinol. 2016;2016:5616807. Epub 2016 Oct 4. Review.

Supplemental Content

Support Center